Manchester Capital Management LLC

Position in ELAN — Elanco Animal Health Inc

CIK 1393389 MANCHESTER, VT

Position in ELAN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,928

+$81 QoQ

Shares Held

119

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#460

of 515 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Manchester Capital Management LLC holds $190,507 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #4 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	4,649	$74,523
2	VTRS	Viatris Inc	4,478	$71,110
3	ZTS	Zoetis Inc.	500	$35,930
4	ELAN	Elanco Animal Health Inc This page	119	$2,928
5	UTHR	UNITED THERAPEUTICS Corp	4	$2,167
6	NBIX	Neurocrine Biosciences Inc	11	$1,853
7	ALKS	Alkermes plc.	20	$1,048
8	TEVA	Teva Pharmaceutical Industries Ltd	28	$948

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,928	119	0.0%	Shares	Sole	2026-08-13
2026-03-31	$2,847	119	0.0%	Shares	Sole	2026-05-11
2025-12-31	$2,692	119	-96.1%	Shares	Sole	2026-02-11
2022-06-30	$59,321	3,022	0.0%	Shares	Sole	2022-08-10
2022-03-31	$78,843	3,022	0.0%	Shares	Sole	2022-05-09
2021-12-31	$85,764	3,022	-49.0%	Shares	Sole	2022-02-10
2021-09-30	$189,107	5,930	+109.6%	Shares	Sole	2021-11-12
2021-06-30	$98,138	2,829	+8.8%	Shares	Sole	2021-08-16
2021-03-31	$76,570	2,600	0.0%	Shares	Sole	2021-05-13
2020-12-31	$79,742	2,600	0.0%	Shares	Sole	2021-02-16
2020-09-30	$72,618	2,600	0.0%	Shares	Sole	2020-10-27
2020-06-30	$55,770	2,600	0.0%	Shares	Sole	2020-09-28
2020-03-31	$58,214	2,600	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.